Quoin Pharmaceuticals Receives EMA Orphan Drug Designation for QRX003
The EMA granted orphan drug designation to QRX003 for Peeling Skin Syndrome. Quoin plans to start its first formal clinical study before year-end.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.